The Equivalence of Stereotactic Body Radiation Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer Stratified by 2015 NCCN Risk Groups

Journal article

G. Manahan, A. Ricco, M. Bernetich, R.M. Lanciano, J. Yang, A. Hanlon, S.A. Arrigo, J.P. Lamond and L.W. Brady

International journal of radiation oncology, biology, physics, v 93(3), pp E217-E217

01 Nov 2015

Additional Links

11 Record Views

Title: The Equivalence of Stereotactic Body Radiation Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer Stratified by 2015 NCCN Risk Groups
Creators: G. Manahan - Drexel University
A. Ricco - Thomas Jefferson University
M. Bernetich - Rowan University
R.M. Lanciano - Drexel University
J. Yang - Drexel University
A. Hanlon - University of Pennsylvania, Philadelphia PA.
S.A. Arrigo - Delaware County Memorial Hospital
J.P. Lamond - Drexel University
L.W. Brady - Drexel University
Publication Details: International journal of radiation oncology, biology, physics, v 93(3), pp E217-E217
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Radiation Oncology (and Nuclear Medicine)
Web of Science ID: WOS:000373215300543
Other Identifier: 991019201388104721

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Domestic collaboration
Web of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging